首页|系统干预对巨大胸腺瘤患者术后并发肌无力危象的预防效果

系统干预对巨大胸腺瘤患者术后并发肌无力危象的预防效果

Preventive effect of systematic nursing on postoperative myasthenic crisis in patients with giant thymomas

扫码查看
目的 探讨系统干预对巨大胸腺瘤患者术后并发肌无力危象的预防效果.方法 抽选 2020 年 1 月至2022 年3 月行手术治疗且符合纳入标准的巨大胸腺瘤患者64 例,按随机数表法分为对照组和观察组,每组32 例.对照组予以常规干预,观察组予以系统干预,比较 2 组的干预效果.结果 观察组呼吸机使用时间、入住ICU时间及平均住院时间均短于对照组,差异有统计学意义(P<0.05).对照组总遵医率为84.38%,观察组总遵医率为93.75%,观察组高于对照组,差异有统计学意义(P<0.05).观察组肌无力危象发生率及其他并发症发生率均少于对照组,差异有统计学意义(P<0.05).观察组患者总满意度 93.75%显著高于对照组的 75.00%,差异有统计学意义(P<0.05).结论 对巨大胸腺瘤患者实施系统干预,能够加强预防术后肌无力危象及相关并发症发生,改善患者多项临床指标,提高患者的满意度.
Objective To investigate the preventive effect of systematic nursing on postoperative myasthenic crisis in patients with giant thymomas.Methods A total of 64 eligible patients with giant thymomas who underwent surgical treatment in our hospital from January 2020 to March 2022 were selected and divided into groups according to the random number table method,with 32 cases in each group.Patients in the control group were given routine nursing,while those in the observation group were given systematic nursing.Intervention outcomes were compared between groups.Results The ventilator use time,ICU stay time and average hospital stay in the observation group were significantly shorter than those of the control group(P<0.05).After interventions,the total compliance rate in the observation group was significantly higher than that of the control group(93.75%vs 84.38%,P<0.05).The incidence of myasthenic crisis and other complications in the observation group was significantly lower than that of the control group(P<0.05)The total satisfaction of the observation group was significantly higher than that of the control group(93.75%vs 75.00%,P<0.05).Conclusion The implementation of systematic nursing for patients with giant thymomas can strengthen the prevention of postoperative myasthenic crisis and related complications,and improve a number of clinical indicators and satisfaction.

giant thymomamyasthenic crisissystematic nursingompliance ratesatisfaction

鹿振辉、盖恬恬、韩遵海、石颖、侯世峰、赵海颖

展开 >

100730 北京市,首都医科大学附属北京同仁医院重症医学科

巨大胸腺瘤 肌无力危象 系统干预 遵医率 满意度

首都医科大学附属北京同仁医院青年人才培养计划种子基金资助项目

2019-YJJ-ZZL-050

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(9)
  • 20